Can You Get Lasik If You Have Psoriasis?

How Psoriasis Affects the Eyes — What LASIK Surgeons Assess

Psoriasis is an autoimmune condition in which the immune system drives accelerated skin cell turnover, producing the characteristic plaques of inflamed, scaly skin. Beyond the skin, psoriasis has several ocular manifestations that are directly relevant to LASIK candidacy — not all psoriasis patients experience them, but each one must be specifically assessed before surgery.

Dry Eye Syndrome

Dry eye is the most common and clinically significant ocular consequence of psoriasis for LASIK purposes. Several mechanisms drive it: meibomian gland dysfunction — impaired oil gland function at the eyelid margin — disrupts the tear film’s lipid layer; systemic inflammation affects lacrimal gland function; and the medications used to manage psoriasis can themselves affect tear film quality. LASIK surgery temporarily disrupts corneal nerves that trigger tear production, compounding pre-existing dryness. A patient with significant pre-existing dry eye who undergoes LASIK is at substantially elevated risk of post-operative dry eye that is more severe and more prolonged than standard.

Blepharitis

Blepharitis — inflammation of the eyelid margins — occurs in a meaningful proportion of psoriasis patients, and it is a clinically relevant LASIK consideration because it creates chronic bacterial colonisation and inflammation at the eyelid edge. This proximity to the surgical site increases infection risk during the post-operative period. Active blepharitis must be treated and controlled before LASIK proceeds. Our resource on blepharitis treatment covers the management pathway and the clinical criteria for confirming adequate control before refractive surgery.

Uveitis and Conjunctivitis

These inflammatory eye conditions occur less commonly in psoriasis but represent more significant LASIK contraindications when present. Active uveitis — inflammation of the uveal tract — is an absolute contraindication for LASIK while the episode is ongoing. It must be fully resolved, with a clinically stable period confirmed by an ophthalmologist, before surgery is considered.

Psoriatic Arthritis — Eye Involvement

Approximately 30% of psoriasis patients develop psoriatic arthritis, and eye involvement — primarily anterior uveitis — occurs in a subset. If your psoriasis is accompanied by psoriatic arthritis with known eye involvement, your pre-operative assessment must specifically address this history and confirm current eye stability.

Factors That Determine LASIK Candidacy With Psoriasis

Disease Activity and Timing

The most fundamental candidacy requirement for a psoriasis patient considering LASIK is that the disease is stable. An active psoriasis flare represents a state of heightened systemic immune activation that affects wound healing across the body — including the corneal stroma. Patients who undergo surgery during a flare consistently show less predictable healing trajectories than those who proceed during stable remission. Surgeons typically look for a minimum of three to six months of clinical stability before scheduling LASIK for psoriasis patients.

Severity and Location of Skin Involvement

Psoriasis affecting the skin around the eyes, eyelids, or brow introduces additional risk from scale debris and bacterial load in the surgical vicinity. This does not automatically disqualify candidates, but it does require that this involvement be fully treated and under control before surgery.

Tear Film Quality

A comprehensive dry eye evaluation — including tear break-up time, Schirmer’s testing, and meibography — is essential for every psoriasis patient being evaluated for LASIK. The results determine not just whether LASIK is appropriate but what level of pre-operative dry eye management is needed, and whether the dry eye history makes a flapless procedure preferable to standard LASIK.

General Eye Health

Standard LASIK candidacy criteria — adequate corneal thickness, stable prescription for at least 12 months, no active ocular disease — all apply to psoriasis patients in addition to the psoriasis-specific assessment. Our guide on medical conditions that affect LASIK candidacy gives a broader framework for how systemic health conditions are evaluated in the LASIK candidacy process, which provides helpful context alongside the psoriasis-specific considerations in this article.

Immunosuppressive Medications — The Key Conversation

This is the section most psoriasis patients need most. Many moderate-to-severe psoriasis patients manage their condition with systemic immunosuppressive medications — methotrexate, cyclosporine, or biologic agents (adalimumab, secukinumab, ustekinumab, and others). These medications work by reducing the immune response that drives psoriasis. They also, by the same mechanism, reduce the immune activity that drives wound healing after surgery.

The clinical implications are nuanced and medication-specific. Methotrexate, for example, has known effects on cellular proliferation that can slow epithelial healing. Biologic agents have different immunomodulatory profiles and interact with post-surgical healing in ways that are still being characterised in the refractive surgery literature. None of these medications are absolute LASIK contraindications — but all of them require disclosure and discussion with your ophthalmologist and dermatologist in advance of surgery.

The discussion typically covers three questions: Is temporary medication adjustment feasible and safe given your psoriasis control? What does your dermatologist advise about peri-operative medication management? And does the combined risk profile — given your medication, your dry eye status, and your disease activity — make LASIK the most appropriate choice versus a flapless alternative? This coordinated consultation is how psoriasis patients arrive at a genuinely informed surgical decision. The broader clinical comparison between how different systemic conditions affect LASIK candidacy — including how diabetes management parallels psoriasis management in several ways — is covered in our guide on LASIK for diabetics.

How to Prepare for LASIK With Psoriasis

If your evaluation confirms that you are a suitable candidate, pre-operative preparation for psoriasis patients has several specific components:

Coordinated Specialist Consultation

Schedule a coordinated consultation with your dermatologist and ophthalmologist before making a surgical decision. The ophthalmologist assesses ocular candidacy; the dermatologist advises on disease stability and medication management peri-operatively. These specialists ideally communicate directly rather than through the patient alone.

Treat Active Ocular Complications First

Blepharitis, significant dry eye, and any inflammatory eye condition must be adequately controlled before proceeding. This is not a deferral — it is a prerequisite. For patients with blepharitis, a consistent lid hygiene routine combined with appropriate treatment typically produces adequate control within several weeks. For patients with significant dry eye, a management programme including lubricating drops, omega-3 supplementation, and in some cases punctal occlusion should be initiated and assessed before surgery. Our resource on punctal plugs for dry eyes explains this additional intervention option for patients whose dry eye is not adequately controlled by drops alone.

Choose the Right Timing

Surgery during stable remission — not within or shortly after a flare — is the fundamental timing principle. Your surgeon should have documented evidence of stability at the time of the pre-operative assessment rather than a patient’s verbal report alone.

Post-Operative Care for Psoriasis Patients

Post-operative care for psoriasis patients follows the standard LASIK protocol with specific additions:

• Intensive dry eye management: Lubricating drops should be applied more frequently than the standard recommendation — discuss a specific schedule with your surgeon based on your baseline tear film assessment.
• Blepharitis maintenance: If blepharitis was present pre-operatively, lid hygiene and treatment must continue through the recovery period — not just until surgery day.
• Monitoring for delayed healing: Patients on immunosuppressive medications may show slower epithelial recovery. All post-operative reviews must specifically assess healing progress rather than assuming standard timelines.
• Psoriasis flare prevention: The physical stress of surgery can sometimes trigger psoriasis activity. Discuss with your dermatologist whether any additional psoriasis management is warranted in the peri-operative period.
• Report unusual symptoms promptly: Any extended redness, pain, vision disturbance, or ocular surface changes should be reported at the first sign — do not wait for scheduled appointments.

Vision Correction Alternatives if LASIK Is Not Suitable

PRK — Preferred Flapless Option for Immune-Compromised Patients

If LASIK is contraindicated — most commonly due to significant dry eye, thin corneas, or medication concerns — PRK is the first alternative considered for most psoriasis patients. PRK removes the epithelium to access the corneal stroma directly, ablating tissue without creating a flap. The absence of a flap eliminates the flap-related complications relevant to immune-compromised healing and removes the flap-interface dry eye contribution. Recovery is longer than LASIK — five to seven days for functional vision rather than 24 hours — but the surface ablation approach is better tolerated by patients whose healing is affected by immune modulation.

ICL — For Patients Who Cannot Have Corneal Laser Surgery

EVO ICL (Implantable Collamer Lens) is an additive surgical option that corrects refractive error by implanting a soft biocompatible lens inside the eye without removing any corneal tissue. For psoriasis patients whose dry eye severity or corneal profile makes any form of laser surgery inappropriate, ICL removes the corneal surface from the surgical equation entirely. The implant sits between the iris and natural crystalline lens, corrects the refractive error, and can be removed if necessary. It does not depend on corneal healing for its optical effect, which makes it particularly relevant for patients with ocular surface conditions that make corneal-based procedures high risk. Our overview of EVO ICL eye surgery explains the candidacy criteria and what the implant procedure involves for patients weighing this option.